Manufacturer record
Taksa Lifescience E-47: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Taksa Lifescience E-47 (Chandigarh) was declared Not of Standard Quality in May 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: TLT-6938, Zaflox-OZ Tablet (exp Jan 2026). Modern Drug Testing Laboratory Kathua (J&K) (state lab) found it not of standard quality: 1.The sample fails in the Dissolution Test of Ofloxacin IP & Ornidazole IP 2.The sample does not conform to the Assay content of Ofloxacin. Listed in the May 2025 alert.
Records by type
1 record linked to Taksa Lifescience E-47 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Zaflox-OZ Tablet | Batch TLT-6938Mfg Feb 2024 · Exp Jan 2026 | 1.The sample fails in the Dissolution Test of Ofloxacin IP & Ornidazole IP 2.The sample does not conform to the Assay content of Ofloxacin IP 3.The sample is also found Misbranded as Ofloxacin and Ornidazole Tablets are not been shown official as per I.P 2022Assay | Modern Drug Testing Laboratory Kathua (J&K)State lab | May 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.